Vita Life Sciences Limited (ASX:VLS – Get Free Report) insider Henry Townsing sold 100,000 shares of the company’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of A$2.10 ($1.35), for a total value of A$210,000.00 ($135,483.87).
Henry Townsing also recently made the following trade(s):
- On Wednesday, March 27th, Henry Townsing 300,000 shares of Vita Life Sciences stock.
Vita Life Sciences Price Performance
The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.57 and a current ratio of 2.98.
Vita Life Sciences Increases Dividend
About Vita Life Sciences
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints.
Read More
- Five stocks we like better than Vita Life Sciences
- What is the Euro STOXX 50 Index?
- Comprehensive Analysis of PayPal Stock
- Where Do I Find 52-Week Highs and Lows?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- What Are Dividend Champions? How to Invest in the Champions
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.